Skip to content

Drug interactions

Belzutifan + Dexamethasone-neomycin-polymyxin

Severity: Minor

Belzutifan and Dexamethasone-neomycin-polymyxin: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Belzutifan induces CYP3A4 and may lower exposure to CYP3A4 substrates such as dexamethasone. With a topical or ophthalmic dexamethasone combination, systemic exposure is small, so the effect is unlikely to matter clinically.

What this interaction means in plain words

Belzutifan and Dexamethasone-neomycin-polymyxin have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Belzutifan belongs to Miscellaneous; Dexamethasone-neomycin-polymyxin belongs to Anti Bacterial.

Evidence level: Low

Why it happens

Belzutifan induces CYP3A4, increasing dexamethasone metabolism.

What to do

No dose change is usually needed for topical or ophthalmic use; if the response to dexamethasone appears reduced, reassess the treatment.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Belzutifan and Dexamethasone-neomycin-polymyxin, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Belzutifan with Dexamethasone-neomycin-polymyxin?

MediHelp rates the interaction as minor. Belzutifan and Dexamethasone-neomycin-polymyxin have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Belzutifan induces CYP3A4 and may lower exposure to CYP3A4 substrates such as dexamethasone. With a topical or ophthalmic dexamethasone combination, systemic exposure is small, so the effect is unlikely to matter clinically.

How serious is the interaction between Belzutifan and Dexamethasone-neomycin-polymyxin?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: No dose change is usually needed for topical or ophthalmic use; if the response to dexamethasone appears reduced, reassess the treatment.

What other medicines interact with Dexamethasone-neomycin-polymyxin?

MediHelp also lists interactions of Dexamethasone-neomycin-polymyxin with, for example, Ketorolac, Lapatinib, Levofloxacin. The full list is on the Dexamethasone-neomycin-polymyxin page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in